机器人辅助与胸腔镜下心脏肿瘤切除术的对比研究OA

Objective:To compare the clinical outcomes of robot-assisted and totally thoracoscopic cardiac tumor resection,evaluate the safety and efficacy of the robotic surgical system and summarize preliminary experience.Methods:A retrospective analysis was conducted on 59 patients who underwent minimally invasive cardiac tumor resection at the Department of Cardiovascular Surgery at the First Affiliated Hospital of Nanjing Medical University between September 2018 and March 2025.Based on the surgical approach,patients were divided into the robotic group(n=24)and the thoracoscopic group(n=35).Perioperative indicators and follow-up outcomes were compared between the two groups.Results:All surgeries were successfully completed.Compared to the thoracoscopic group,the robotic group showed significantly lower 24h drainage,shorter cardiopulmonary bypass time,aortic cross-clamp time,and postoperative ventilator-assisted time(P<0.05).There were no statistically significant differences between the two groups in terms of postoperative hospital stay,total operative time,intraoperative RBC infusion,postoperative length of ICU stay,size of arteriovenous catheter,postoperative incidence of stroke,and co-occurrence of other surgeries(P>0.05).No tumor recurrence was observed in any patient during the follow-up.Conclusion:Robot-assisted cardiac tumor resection is safe and effective,which can achieve comparable long-term outcomes to total thoracoscopic surgery.For patients with broad-based or large-volume tumors,robot-assisted surgery has significant advantages.